0001773751-23-000323.txt : 20231229 0001773751-23-000323.hdr.sgml : 20231229 20231229180906 ACCESSION NUMBER: 0001773751-23-000323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231227 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dudum Andrew CENTRAL INDEX KEY: 0001837796 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 231528954 MAIL ADDRESS: STREET 1: 2269 CHESTNUT STREET, #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wk-form4_1703891337.xml FORM 4 X0508 4 2023-12-27 0 0001773751 Hims & Hers Health, Inc. HIMS 0001837796 Dudum Andrew 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 1 1 1 0 Chief Executive Officer 1 Class A Common Stock 2023-12-27 4 M 0 7700 2.43 A 59353 D Class A Common Stock 2023-12-27 4 S 0 7700 9.0211 D 51653 D Class A Common Stock 2023-12-28 4 M 0 25750 2.43 A 77403 D Class A Common Stock 2023-12-28 4 S 0 25750 9.0098 D 51653 D Class A Common Stock 2023-12-29 4 M 0 21432 2.43 A 73085 D Class A Common Stock 2023-12-29 4 S 0 21432 9.0623 D 51653 D Class A Common Stock 1315881 I Held by Trustee of AD 2022 GRAT 3 Class A Common Stock 1743758 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Class A Common Stock 1675943 I Held by Trustee of AD 2021 GRAT dated 11-1-2021 Class A Common Stock 597335 I Held by Trustee of AD 2022 GRAT Class A Common Stock 570398 I Held by Trustee of Dudum Family Community Property Trust Class A Common Stock 418986 I Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021 Class A Common Stock 1584506 I Held by Trustee of AD 2023 GRAT dated 9-5-2023 Class A Common Stock 891735 I Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022 Class A Common Stock 1500 I Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997 Class A Common Stock 2874769 I Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 Stock Option (right to buy) 2.43 2023-12-27 4 M 0 7700 0 D 2030-06-17 Class A Common Stock 7700 2980064 D Stock Option (right to buy) 2.43 2023-12-28 4 M 0 25750 0 D 2030-06-17 Class A Common Stock 25750 2954314 D Stock Option (right to buy) 2.43 2023-12-29 4 M 0 21432 0 D 2030-06-17 Class A Common Stock 21432 2932882 D The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.035. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.01 - $9.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. /s/ Kimberly Mather, Attorney-in-Fact 2023-12-29